Aciculatin induces p53-dependent apoptosis via MDM2 depletion in human cancer cells in vitro and in vivo

Chin Yu Lai, An Chi Tsai, Mei Chuan Chen, Li Hsun Chang, Hui Lung Sun, Ya Ling Chang, Chien Chih Chen, Che Ming Teng, Shiow Lin Pan

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Aciculatin, a natural compound extracted from the medicinal herb Chrysopogon aciculatus, shows potent anti-cancer potency. This study is the first to prove that aciculatin induces cell death in human cancer cells and HCT116 mouse xenografts due to G1 arrest and subsequent apoptosis. The primary reason for cell cycle arrest and cell death was p53 accumulation followed by increased p21 level, dephosphorylation of Rb protein, PUMA expression, and induction of apoptotic signals such as cleavage of caspase-9, caspase-3, and PARP. We demonstrated that p53 allele-null (-/-) (p53-KO) HCT116 cells were more resistant to aciculatin than cells with wild-type p53 (+/+). The same result was achieved by knocking down p53 with siRNA in p53 wild-type cells, indicating that p53 plays a crucial role in aciculatin-induced apoptosis. Although DNA damage is the most common event leading to p53 activation, we found only weak evidence of DNA damage after aciculatin treatment. Interestingly, the aciculatin-induced downregulation of MDM2, an important negative regulator of p53, contributed to p53 accumulation. The anti-cancer activity and importance of p53 after aciculatin treatment were also confirmed in the HCT116 xenograft models. Collectively, these results indicate that aciculatin treatment induces cell cycle arrest and apoptosis via inhibition of MDM2 expression, thereby inducing p53 accumulation without significant DNA damage and genome toxicity.

Original languageEnglish
Article numbere42192
JournalPLoS One
Volume7
Issue number8
DOIs
Publication statusPublished - Aug 13 2012
Externally publishedYes

Fingerprint

DNA damage
apoptosis
Cells
Apoptosis
Chrysopogon aciculatus
cell death
caspase-9
Neoplasms
neoplasms
null alleles
dephosphorylation
cells
caspase-3
small interfering RNA
DNA Damage
HCT116 Cells
medicinal plants
Cell death
protein synthesis
Cell Cycle Checkpoints

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Aciculatin induces p53-dependent apoptosis via MDM2 depletion in human cancer cells in vitro and in vivo. / Lai, Chin Yu; Tsai, An Chi; Chen, Mei Chuan; Chang, Li Hsun; Sun, Hui Lung; Chang, Ya Ling; Chen, Chien Chih; Teng, Che Ming; Pan, Shiow Lin.

In: PLoS One, Vol. 7, No. 8, e42192, 13.08.2012.

Research output: Contribution to journalArticle

Lai, Chin Yu ; Tsai, An Chi ; Chen, Mei Chuan ; Chang, Li Hsun ; Sun, Hui Lung ; Chang, Ya Ling ; Chen, Chien Chih ; Teng, Che Ming ; Pan, Shiow Lin. / Aciculatin induces p53-dependent apoptosis via MDM2 depletion in human cancer cells in vitro and in vivo. In: PLoS One. 2012 ; Vol. 7, No. 8.
@article{b7a170f071ff4f6492b2febb317a7c3e,
title = "Aciculatin induces p53-dependent apoptosis via MDM2 depletion in human cancer cells in vitro and in vivo",
abstract = "Aciculatin, a natural compound extracted from the medicinal herb Chrysopogon aciculatus, shows potent anti-cancer potency. This study is the first to prove that aciculatin induces cell death in human cancer cells and HCT116 mouse xenografts due to G1 arrest and subsequent apoptosis. The primary reason for cell cycle arrest and cell death was p53 accumulation followed by increased p21 level, dephosphorylation of Rb protein, PUMA expression, and induction of apoptotic signals such as cleavage of caspase-9, caspase-3, and PARP. We demonstrated that p53 allele-null (-/-) (p53-KO) HCT116 cells were more resistant to aciculatin than cells with wild-type p53 (+/+). The same result was achieved by knocking down p53 with siRNA in p53 wild-type cells, indicating that p53 plays a crucial role in aciculatin-induced apoptosis. Although DNA damage is the most common event leading to p53 activation, we found only weak evidence of DNA damage after aciculatin treatment. Interestingly, the aciculatin-induced downregulation of MDM2, an important negative regulator of p53, contributed to p53 accumulation. The anti-cancer activity and importance of p53 after aciculatin treatment were also confirmed in the HCT116 xenograft models. Collectively, these results indicate that aciculatin treatment induces cell cycle arrest and apoptosis via inhibition of MDM2 expression, thereby inducing p53 accumulation without significant DNA damage and genome toxicity.",
author = "Lai, {Chin Yu} and Tsai, {An Chi} and Chen, {Mei Chuan} and Chang, {Li Hsun} and Sun, {Hui Lung} and Chang, {Ya Ling} and Chen, {Chien Chih} and Teng, {Che Ming} and Pan, {Shiow Lin}",
year = "2012",
month = "8",
day = "13",
doi = "10.1371/journal.pone.0042192",
language = "English",
volume = "7",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "8",

}

TY - JOUR

T1 - Aciculatin induces p53-dependent apoptosis via MDM2 depletion in human cancer cells in vitro and in vivo

AU - Lai, Chin Yu

AU - Tsai, An Chi

AU - Chen, Mei Chuan

AU - Chang, Li Hsun

AU - Sun, Hui Lung

AU - Chang, Ya Ling

AU - Chen, Chien Chih

AU - Teng, Che Ming

AU - Pan, Shiow Lin

PY - 2012/8/13

Y1 - 2012/8/13

N2 - Aciculatin, a natural compound extracted from the medicinal herb Chrysopogon aciculatus, shows potent anti-cancer potency. This study is the first to prove that aciculatin induces cell death in human cancer cells and HCT116 mouse xenografts due to G1 arrest and subsequent apoptosis. The primary reason for cell cycle arrest and cell death was p53 accumulation followed by increased p21 level, dephosphorylation of Rb protein, PUMA expression, and induction of apoptotic signals such as cleavage of caspase-9, caspase-3, and PARP. We demonstrated that p53 allele-null (-/-) (p53-KO) HCT116 cells were more resistant to aciculatin than cells with wild-type p53 (+/+). The same result was achieved by knocking down p53 with siRNA in p53 wild-type cells, indicating that p53 plays a crucial role in aciculatin-induced apoptosis. Although DNA damage is the most common event leading to p53 activation, we found only weak evidence of DNA damage after aciculatin treatment. Interestingly, the aciculatin-induced downregulation of MDM2, an important negative regulator of p53, contributed to p53 accumulation. The anti-cancer activity and importance of p53 after aciculatin treatment were also confirmed in the HCT116 xenograft models. Collectively, these results indicate that aciculatin treatment induces cell cycle arrest and apoptosis via inhibition of MDM2 expression, thereby inducing p53 accumulation without significant DNA damage and genome toxicity.

AB - Aciculatin, a natural compound extracted from the medicinal herb Chrysopogon aciculatus, shows potent anti-cancer potency. This study is the first to prove that aciculatin induces cell death in human cancer cells and HCT116 mouse xenografts due to G1 arrest and subsequent apoptosis. The primary reason for cell cycle arrest and cell death was p53 accumulation followed by increased p21 level, dephosphorylation of Rb protein, PUMA expression, and induction of apoptotic signals such as cleavage of caspase-9, caspase-3, and PARP. We demonstrated that p53 allele-null (-/-) (p53-KO) HCT116 cells were more resistant to aciculatin than cells with wild-type p53 (+/+). The same result was achieved by knocking down p53 with siRNA in p53 wild-type cells, indicating that p53 plays a crucial role in aciculatin-induced apoptosis. Although DNA damage is the most common event leading to p53 activation, we found only weak evidence of DNA damage after aciculatin treatment. Interestingly, the aciculatin-induced downregulation of MDM2, an important negative regulator of p53, contributed to p53 accumulation. The anti-cancer activity and importance of p53 after aciculatin treatment were also confirmed in the HCT116 xenograft models. Collectively, these results indicate that aciculatin treatment induces cell cycle arrest and apoptosis via inhibition of MDM2 expression, thereby inducing p53 accumulation without significant DNA damage and genome toxicity.

UR - http://www.scopus.com/inward/record.url?scp=84865050263&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865050263&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0042192

DO - 10.1371/journal.pone.0042192

M3 - Article

C2 - 22912688

AN - SCOPUS:84865050263

VL - 7

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 8

M1 - e42192

ER -